The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•20 April 2026•

1 min read

Intelligent Bio Solutions Starts Study to Cut Drug Screening Time by 70%

Key Facts

1The company initiated a validation study for a drug screening cartridge aiming to reduce analysis time by 70%.

2The study targets results in sub-3 minutes, down from the current 10-minute analysis time.

Intelligent Bio Solutions (INBS) has officially initiated a validation study for its new rapid drug screening cartridge, marking a significant advancement in medical testing technology. The study aims to reduce analysis time by 70%, targeting results in under 3 minutes compared to the current 10-minute benchmark. This innovative product is specifically designed to capture the global roadside testing market, where speed and accuracy are critical. The company expects this development to strengthen its competitive position and expand its market share within the specialized medical devices sector. Investors are closely monitoring the study's outcomes as a potential catalyst for future revenue growth. This move underscores the company's commitment to technical innovation in meeting the demands of global regulatory and law enforcement agencies.